HSC01
clear graphic clear graphic
clear graphic

Scientists find a new way insulin-producing cells die

Posted on Friday, February 25, 2011


clear graphicclear graphic
clear graphicclear graphic
clear graphicEmail Printer Friendly Format
 

Print contact: Will Sansom, (210) 567-2579
Broadcast contact: Lucie Portela, (210) 567-3026

SAN ANTONIO, Texas, U.S.A. (Feb. 25, 2011) — The death of insulin-producing beta cells in the pancreas is a core defect in diabetes. Scientists in Italy and Texas now have discovered a new way that these cells die — by toxic imbalance of a molecule secreted by other pancreatic cells.

“Our study shows that neighboring cells called alpha cells can behave like adversaries for beta cells. This was an unexpected finding,” said Franco Folli, M.D., Ph.D., professor of medicine/diabetes at The University of Texas Health Science Center at San Antonio. He is co-lead author on the study with Carla Perego, Ph.D., assistant professor of physiology at the University of Milan.

Alpha and beta cells are grouped in areas of the pancreas called the islets of Langerhans. Alpha cells make the hormone that raises blood sugar, glucagon, during fasting. In the same environment the beta cells make the hormone that lowers sugars, insulin, after a meal. Imbalance ultimately leads to diabetes.

“We found that glutamate, a major signaling molecule in the brain and pancreas, is secreted together with glucagon by alpha cells and affects beta cell integrity,” Dr. Folli said. “In a situation where there is an imbalance toward more alpha cells and fewer beta cells, as in Type 1 and Type 2 diabetes, this could result in further beta cell destruction.”

Glutamate toxicity is a new mechanism of beta cell destruction not previously known, Drs. Perego and Folli said. It has not been typically thought that alpha cells could themselves be a cause of beta cell damage, they said.

The study also found a protection for beta cells, namely, a protein called GLT1 that controls glutamate levels outside the beta cells. “GLT1 is like a thermostat controlling the microenvironment of beta cells with respect to glutamate concentration,” Dr. Perego said.

A diagnostic test for glutamate toxicity in the islets of Langerhans is being developed by the authors, Dr. Folli said. Eventually an intervention to slow the process could follow.

Glutamate poisoning is a new candidate mechanism for beta cell destruction in diabetes. Others are high glucose, buildup of a protein called amyloid, and free fatty acids, which are found in patients with type 2 diabetes.

“The vicious cycle in diabetes is that there are several substances that have been shown, also by us, to be toxic to beta cells,” Dr. Folli said. “And now we have found a new one, glutamate.”

The Journal of Biological Chemistry published the study online this week. The work of Dr. Perego is supported by a grant from the Italian Ministry of University. Dr. Folli’s work is supported by the National Institutes of Health. The authors said the finding emphasizes the importance of international collaborations in biomedical knowledge advancement.

# # #


The University of Texas Health Science Center at San Antonio, one of the country’s leading health sciences universities, ranks in the top 3 percent of all institutions worldwide receiving U.S. federal funding. Research and other sponsored program activity totaled $228 million in fiscal year 2010. The university’s schools of medicine, nursing, dentistry, health professions and graduate biomedical sciences have produced approximately 26,000 graduates. The $744 million operating budget supports eight campuses in San Antonio, Laredo, Harlingen and Edinburg. For more information on the many ways “We make lives better®,” visit www.uthscsa.edu.

 
Share |


bottom bar

»printer friendly format...
»view more articles by issue#...
»search articles by keywords...
Arrow - to top
Arrow - to top